An updated trial analysis presented at AACR 2026 showed that the investigational KRAS G12D inhibitor zoldonrasib demonstrated clinical activity with a favorable safety profile in previously treated KRAS G12D‑mutant NSCLC patients
In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes
Extended immunotherapy showed manageable long‑term safety in adolescents and young adults with alveolar soft part sarcoma, according to phase II data presented at AACR 2026
The AACR will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology
At-home self-collection reduces significant barriers for unscreened or under-screened individuals
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments
Meeting co‑chairs Dr. Paul Mischel and Dr. Alice Shaw share the themes, challenges, and scientific momentum shaping this year’s must‑attend event
Collaboration to enable more streamlined end-to-end workflows while maintaining sample integrity
Why software integration is the key to reproducible, data-driven biologics workflows
The bottlenecks of manual ELISA are well known, but modern liquid handling tools offer a practical way to fix them
Minimally invasive blood test enables greater patient access to monitoring of neuroinflammatory status versus current standard of care methods
BIOFIRE SPOTFIRE introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients
Povair Sciences addresses critical bottlenecks in mAb development with innovative filtration solutions
Up to 100 percent transfer efficiency and viability to protect top clones for downstream expansion
